"GLP-1 RAs [receptor agonists] may have antidepressant and anti-anxiety effects, potentially due to their anti-inflammatory and anti-oxidative properties, which can also help reduce neuroinflammation."
"The research indicates that appetite-suppressing injections improve mood and quality of life more than insulin and other antidiabetic drugs, signifying their broader health benefits."
A study from the University of Bern indicates that appetite-suppressing injections, originally for diabetes, improve mental health alongside curbing appetite. The findings suggest that glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, enhance mood and wellbeing, even more so than traditional antidiabetic medications. This is significant as many working-age individuals in England and Wales struggle with long-term mental health issues. The study reports positive effects in patients taking psychiatric medications, indicating these treatments could mitigate mental illness without adverse effects on mental health.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]